leisure time -WSS

leisure time

author：knowledge 2025-09-27 19:01:57 - browse：8124

The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical trial, may have contributed to the death in June of a patient in the study, STAT has learned.

One investigator on the study flagged the death, noting it came after the patient experienced bleeding in the brain, and concluded it was related to the drug, according to documents obtained by STAT. Eisai, the drugmaker behind lecanemab, disagreed, pointing to other possible factors, including a series of setbacks in preceding months — multiple falls, a heart attack, a respiratory infection, and mini-stroke-like events.

Though still under investigation, the death suggests that new medicines to treat Alzheimer’s, like medicines to treat anything else, will come with their own side effects and costs. It also raises the importance of waiting for the full lecanemab data before drawing conclusions based on the positive press release put out by Eisai and its partner Biogen last month.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Pfizer's Covid pill remains 89% effective in final analysis, company says

WSS

New safety details link Apellis eye drug to rare cases of blindness

New safety details link Apellis eye drug to rare cases of blindness

Physician groups backed by private equity giant lobby on mergers

What to expect as Trump is arraigned on his Jan 6. indictment

Why is France rioting? What to know about the fatal police shooting of Nahel M

These geoengineering technologies could help combat the climate crisis, scientists say

focus

leisure time

leisure time

Wildfire smoke exposes gaps in outdoor worker protections

No plane should take off without an EpiPen onboard

Guidelines to prevent youth baseball injuries need more muscle

Doctor appointment wait times are getting worse

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Infectious disease expert Jeanne Marrazzo assumes Fauci role

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

NIH launches clinical trials and new research office for long Covid

Peter Hotez and the public health issue of online harassment

4th of July breaks record for highest global temperature ever measured

focus

National panel will explore requiring free Covid tests

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Wildfire pollution widens asthma inequities on Long Island

New safety details link Apellis eye drug to rare cases of blindness

Vertex non

National panel will explore requiring free Covid tests

focus

knowledge

knowledge

focus